IGFR-1 kinase inhibitors (Nerviano)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIGFR-1 kinase inhibitors (Nerviano)
Drug Alias Nameinsulin-like growth factor-1 receptor tyrosine kinase inhibitor (Nerviano)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor antagonistsNerve growth factor receptor Trk-A inhibitors
TargetsNerve growth factor receptor Trk-AInsulin-like growth factor I receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNerviano Medical Sciences Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNerviano Medical Sciences Srl
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A